Opinion about reproductive decision making among individuals undergoing BRCA1/2 genetic testing in a multicentre Spanish cohort

Human Reproduction

Volumn 24, Issue 4, 2009, Pages 1000-1006

  Fortuny, Daniel ^a   Balmaña, Judith ^a   Graña, Begoña ^b   Torres, Asunción ^c   Cajal, Teresa Ramón Y ^d   Darder, Esther ^b   Gadea, Neus ^a   Velasco, Angela ^b   López, Consol ^d   Sanz, Judit ^c   Alonso, Carmen ^d   Brunet, Joan ^b,e  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^c HOSPITAL UNIVERSITARI SANT JOAN DE REUS   (Spain)

^d HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^e GIRONA BIOMEDICAL RESEARCH INSTITUTE IDIBGI   (Spain)

Author keywords

Assisted reproduction; Counselling; Ethics; Gene mutations; Prenatal diagnosis

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADOPTION; ADULT; AGED; ARTICLE; BREAST CANCER; CANCER SCREENING; CANCER SUSCEPTIBILITY; CLINICAL TRIAL; COHORT ANALYSIS; DEMOGRAPHY; ETHICAL DECISION MAKING; FAMILY PLANNING; FEMALE; GENE MUTATION; GENETIC SCREENING; HEALTH CARE PERSONNEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MULTICENTER STUDY; ONCOGENE; PATIENT EDUCATION; PRENATAL DIAGNOSIS; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; REPRODUCTIVE PROCEDURES;

EID: 64949187252     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/den471     Document Type: Article

References (26)

1. Antoniou A, Pharoah PD, Narod S, Risch HA, Eyfjord JE, Hopper JL, Loman N, Olsson H, Johannsson O, Borg A et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 2003;72:1117-1130.
2. BOE. Law 14/2006 about Human Reproduction Assisted Techniques. http://www.boe.es/boe/dias/2006/05/27/pdfs/A19947-19956.pdf accessed on October 31, 2008.
3. Chen S, Parmigiani G. Meta-analysis of BRCA1 and BRCA2 penetrance. J Clin Oncol 2007;25:1329-1333.
4. Domchek SM, Rebbeck TR. Prophylactic oophorectomy in women at increased cancer risk. Curr Opin Obstet Gynecol 2007;19:27-30.
5. Foster C, Watson M, Eeles R, Eccles D, Ashley S, Davidson R, Mackay J, Morrison PJ, Hopwood P, Evans DG. Predictive genetic testing for BRCA1/2 in a UK clinical cohort: three-year follow-up. Br J Cancer 2007;96:718- 724.
6. Kauff ND, Domchek SM, Friebel TM, Robson ME, Lee J, Garber JE, Isaacs C, Evans DG, Lynch H, Eeles RA et al. Risk-reducing salpingo-oophorectomy for the prevention of BRCA1-and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study. J Clin Oncol 2008;26:1331-1337.
7. Levy-Lahad E, Friedman E. Cancer risks among BRCA1 and BRCA2 mutation carriers. Br J Cancer 2007;96:11-15.
8. Lynch HT, Snyder C, Lynch JF, Karatoprakli P, Trowonou A, Metcalfe K, Narod SA, Gong G. Patient responses to the disclosure of BRCA mutation tests in hereditary breast-ovarian cancer families. Cancer Genet Cytogenet 2006;165:91-97.
9. Meiser B. Psychological impact of genetic testing for cancer susceptibility: an update of the literature. Psychooncology 2005;14:1060-1074.
10. Meiser B, Gaff C, Julian-Reynier C, Biesecker BB, Esplen MJ, Vodermaier A, Tibben A. International perspectives on genetic counseling and testing for breast cancer risk. Breast Dis 2006;27:109-125.
11. Menon U, Harper J, Sharma A, Fraser L, Burnell M, El Masry K, Rodeck C, Jacobs I. Views of BRCA gene mutation carriers on preimplantation genetic diagnosis as a reproductive option for hereditary breast and ovarian cancer. Hum Reprod 2007;22:1573-1577. Metcalfe K, Lynch HT, Ghadirian P, Tung N, Olivotto I, Warner E, Olopade OI, Eisen A, Weber B, McLennan J et al. Contralateral breast cancer in BRCA 1 and BRCA2 mutation carriers. J Clin Oncol 2004;22:2328-2335.
12. Milne RL, Osorio A, Cajal TR, Vega A, Llort G, de la Hoya M, Diez O, Alonso MC, Lazaro C, Blanco I et al. The average cumulative risks of breast and ovarian cancer for carriers of mutations in BRCA 1 and BRCA2 attending genetic counseling units in Spain. Clin Cancer Res 2008;14:2861-2869.
13. Offit K, Kohut K, Clagett B, Wadsworth EA, Lafaro KJ, Cummings S, White M, Sagi M, Bernstein D, Davis JG. Cancer genetic testing and assisted reproduction. J Clin Oncol 2006;24:4775-4782.
14. Pasacreta JV. Psychosocial issues associated with genetic testing for breast and ovarian cancer risk: an integrative review. Cancer Invest 2003; 21:588-623.
15. Quinn G, Vadaparampil S, Wilson C, King L, Choi J, Miree C, Friedman S. Attitudes of high-risk women toward preimplantation genetic diagnosis. Fertil Steril. 2008.
16. Quintana JM, Padierna A, Esteban C, Arostegui I, Bilbao A, Ruiz I.
17. Evaluation of the psychometric characteristics of the Spanish version of the hospital anxiety and depression scale. Acta Psychiatr Scand 2003;107:216-221.
18. Rebbeck TR, Friebel T, Lynch HT, Neuhausen SL, van 't Veer L, Garber JE, Evans GR, Narod SA, Isaacs C, Matloff E et al. Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group. J Clin Oncol 2004; 22:1055-1062.
19. Ricart M. Cortar la herencia del cáncer. In: Godó J (ed.). La Vanguardia. La Vanguardia Ediciones, Barcelona, 2008. http://hemeroteca.lavanguardia.es/preview/2008/07/07/pagina-26/72389693/pdf. html? search=marta%20ricart.
20. Robson M, Offit K. Clinical practice. Management of an inherited predisposition to breast cancer. N Engl J Med 2007;357:154-162.
21. Schwartz MD, Lerman C, Brogan B, Peshkin BN, Halbert CH, DeMarco T, Lawrence W, Main D, Finch C, Magnant C et al. Impact of BRCA1/BRCA2 counseling and testing on newly diagnosed breast cancer patients. J Clin Oncol 2004;22:1823-1829.
22. Smith KR, Ellington L, Chan AY, Croyle RT, Botkin JR. Fertility intentions following testing for a BRCA1 gene mutation. Cancer Epidemiol Biomarkers Prev 2004;13:733-740.
23. Spits C, De Rycke M, Van Ranst N, Verpoest W, Lissens W, Van Steirteghem A, Liebaers I, Sermon K. Preimplantation genetic diagnosis for cancer predisposition syndromes. Prenat Diagn 2007; 27:447-456.
24. Van Oostrom I, Meijers-Heijboer H, Lodder LN, Duivenvoorden HJ, van Gool AR, Seynaeve C, van der Meer CA, Klijn JG, van Geel BN, Burger CW et al. Long-term psychological impact of carrying a BRCA 1/2 mutation and prophylactic surgery: a 5-year follow-up study.J Clin Oncol 2003;21:3867-3874.
25. Ware J Jr, Kosinski M, Keller SD. A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996;34:220-233.
26. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361-370.